Oncology Diagnostics Market Intelligence Package

Unparalleled Insights for Strategic Decision-Making

Our reports provide:

• 5-year market forecasts with detailed segmentation and sub-segmentation
• In-depth analysis of market drivers, trends, and challenges
• Comprehensive competitor landscape assessments
• Primary research insights from industry experts

What's Included:

Global Oncology Liquid Biopsy Report, 3rd Edition: 2024-2029:

• In-depth coverage of all liquid biopsy applications, including early detection, therapy selection, MRD / monitoring, pharma research & trials
• Drivers, moderators, and trends of market growth for each application by geography, tumor type, business model (in-house vs. services), and competitor
• Qualitative and quantitative synthesis of interviews with 38 experts and >200 survey respondents

Global Clinical Oncology Biomarker Testing Report, 2nd Edition: 2023-2028:

• In-depth coverage of clinical biomarker testing across cancer type, analyte type, technology class, business model (in-house vs. services), sample type, and geography
• Drivers, moderators, and trends of market growth for each segmentation
• Analysis of key regulatory and reimbursement considerations influencing testing across the U.S., EU, and APAC
• Database of all companion diagnostic approvals from 1997-2023 (with Global license)

Why DeciBio?

• Precision: our forecasts are built on rigorous primary research and proprietary databases, fueled by our industry knowledge
• Expertise: 10+ years of experience in the life science precision medicine space‍
• Custom Team Time Discussions: this purchase comes with 2 hours of DeciBio team time to address any questions you have on the market
• Actionable: these reports outline the biggest gaps and opportunities in the market today

‍